Investors and Media

Press Releases

November 12, 2024

Scholar Rock Reports Third Quarter 2024 Financial Results and Highlights Business Progress

November 4, 2024

Scholar Rock Announces New Preclinical Data for SRK-439 Showing Significant Lean Mass Increase and Enhanced Fat Mass Loss with Metformin

November 1, 2024

Scholar Rock to Host Conference Call to Discuss Third Quarter 2024 Financial Results and Provide Business Update on November 12, 2024

October 31, 2024

Scholar Rock to Participate in Upcoming Investor Conferences

October 31, 2024

Scholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 39th Annual Meeting

October 22, 2024

Scholar Rock Announces Closing of Full Exercise of Option to Purchase Additional Shares in Public Offering

October 18, 2024

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 8, 2024

Scholar Rock Announces Pricing of Upsized $300 Million Public Offering of Common Stock and Pre-Funded Warrants

Archived Press Releases